<DOC>
	<DOCNO>NCT00889265</DOCNO>
	<brief_summary>This prospective , multi-center study evaluate use CopiOs Pericardium Membrane , bovine xenograft , use Puros Cancellous Particulate Allograft , augmentation localize alveolar ridge defect either maxilla mandible .</brief_summary>
	<brief_title>CopiOsÂ® Pericardium Membrane Localized Alveolar Ridge Augmentation</brief_title>
	<detailed_description>The study evaluate use CopiOs Pericardium Membrane ( CopiOs Pericardium ) , bovine xenograft , use Puros Cancellous Particulate Allograft ( Puros Cancellous ) , mineralize allograft , augmentation localize alveolar ridge defect edentulous site . The purpose study determine placement time , ease use , stability , esthetic clinically evaluate efficacy list product . A biopsy take subset patient population , one investigational site , evaluate graft site 's formation new bone . The study hypothesis CopiOs Pericardium Puros Cancellous use , single , localized alveolar ridge defect clinically improve edentulous site .</detailed_description>
	<criteria>Male female , ethnicity , 18 99 year age Health status P1 ( ASA I ) P2 ( ASA II ) , classified American Academy Anesthesiologists Able communicate investigator read , understand , sign inform consent form No evidence active moderate severe periodontitis Must available multiple followup visit duration study The study site must exhibit partially edentulous ridge maxilla mandible least one toothspan length le 5.5 mm small buccolingual dimension measure ridgemapping caliper ( # RIDGECALIPER , Salvin Dental Specialties , Inc. , Charlotte , NC ) . Inability failure maintain adequate oral hygiene Women breadfeeding , pregnant , intend become pregnant study period . Women childbearing potential practicing medically accept method birth control Patients unstable systemic disease Patients compromise immune system ( e.g . uncontrolled diabetes , etc . ) unstable bleed disorder Patients active infectious disease ( e.g . hepatitis , tuberculosis , HEV , etc . ) Patients mental disability may hinder participation study ( e.g . inability follow oral hygiene instruction , postoperative instruction , followup commitment , etc . ) Patients take steroid medication undergo immunosuppressive therapy Radiation , cancer therapy , and/or radiation specifically oral cavity within last 6 month History previous ridge augmentation site interest Augmentation sit localized pathology Patient participate clinical trial within 30 day enrol study , currently enrol another study , plan enroll another study completion study . Unresolved oral pathology ( e.g . periodontal disease , caries , etc . ) Medications condition contraindicate bone regeneration : methotrexate , corticosteroid , history bisphosphonate use , cyclosporineA , etc . Patients minimal tobacco use ( e.g . &gt; 10 cigarette per day ) Other condition investigator may feel would inhibit patient good candidate study contraindicate Directions Use . Note : Careful consideration give alternative therapy prior perform bone graft patient severe endocrineinduced bone disease ( e.g.hyperparathyroidism ) , undergo current therapy drug intervene calcium metabolism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Alveolar Bone Augmentation</keyword>
	<keyword>Implant Surgery</keyword>
	<keyword>Guided Bone Regeneration ( GBR )</keyword>
	<keyword>Guided Tissue Regeneration ( GTR )</keyword>
	<keyword>Bone Graft</keyword>
	<keyword>Periodontal Surgery</keyword>
</DOC>